Warburg Pincus-backed Appasamy Associates acquires German firm RUCK
SENSEX 73,347.55 -362.14 NIFTY 22,706.25 -105.10 CRUDEOIL 9,436.00 + 228.00 GOLD 144,903.00 -1,176.00 SILVER 203,950.00 -5,218.00 SENSEX 73,347.55 -362.14 NIFTY 22,706.25 -105.10 NIFTY 22,706.25 -105.10 CRUDEOIL 9,436.00…

-362.14
NIFTY 22,706.25-105.10
CRUDEOIL 9,436.00+ 228.00
GOLD 144,903.00-1,176.00
SILVER 203,950.00-5,218.00
SENSEX 73,347.55-362.14
NIFTY 22,706.25-105.10
NIFTY 22,706.25-105.10
CRUDEOIL 9,436.00+ 228.00
CRUDEOIL 9,436.00+ 228.00
GOLD 144,903.00-1,176.00
'; } document.getElementById("lgdv").innerHTML = htmlElements; } function numberformat(i) { return Number(parseFloat(i).toFixed(2)).toLocaleString('en', { minimumFractionDigits: 2 }) } async function gatherResponse(response) { const { headers } = response; const contentType = headers.get('content-type') || ''; if (contentType.includes('application/json')) { return await response.json() } return response.text(); } function getWidth() { if (Math.max(document.body.scrollWidth,document.documentElement.scrollWidth,document.body.offsetWidth,document.documentElement.offsetWidth,document.documentElement.clientWidth) > 991) { document.getElementById("mob").style.display = "none"; document.getElementById("lgdv").style.display = "block"; } else { document.getElementById("mob").style.display = "block"; document.getElementById("lgdv").style.display = "none"; } } getWidth(); THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.The acquisition supports Appasamy’s ambition to build a broader global surgical ophthalmology business, bringing together complementary technologies and capabilities into the group
By Sindhu Hariharan
Updated - October 22, 2026 at 03:12 PM.Warburg Pincus-backed Appasamy Associates, a global surgical ophthalmology manufacturer, has acquired RUCK, a German manufacturer of ophthalmic surgical products and systems.
The financial details of the deal remain undisclosed.
Founded in 1978, Appasamy has established a strong presence in ophthalmology, with expertise spanning intraocular lenses (IOLs), surgical systems, diagnostic equipment, lasers and microsurgical instruments.
The company manufactures approximately 5 million IOLs annually, with more than 100 million Appasamy IOLs implanted worldwide, it said in a statement.
The acquisition supports Appasamy’s ambition to build a broader global surgical ophthalmology business, bringing together complementary technologies and capabilities into the group, it said.
Appasamy has established medical technology centres of excellence in Denmark and San Francisco, and this acquisition adds RUCK’s specialised phaco-vitrectomy capabilities to this technology base, while retaining engineering and development in Germany.
RUCK brings more than four decades of experience in ophthalmic surgery. Its portfolio includes the Pentasys, Qube and Qube Pro systems for cataract and vitreoretinal procedures. The Qube Pro and Pentasys systems are widely used and trusted by surgeons in Germany and the Benelux region.
Senthil Kumar, CEO, Appasamy, said, “As part of Appasamy, RUCK will have access to additional resources and capabilities to support the continued development of Qube Pro and its future product offerings. We look forward to working with the RUCK team to build on these strengths and create new opportunities for both businesses.”
In 2024, Warburg Pincus acquired a controlling stake in Appasamy, in what was the PE firm’s largest investment in the healthcare sector in India.
Published on October 22, 2026
THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.Sign into Unlock benefits!- Access 10 free stories per month
- Get notified by email for early preview to new features, discounts & offers
Figures reflect the source report and its stated period. This article is for information and is not investment advice.



